European Commission gives final approval to Moderna vaccine

Marine Strauss
·1-min read
FILE PHOTO: Healthcare workers receive the Moderna COVID-19 vaccine

By Marine Strauss

BRUSSELS (Reuters) - The European Commission gave approval on Wednesday for the use of the COVID-19 vaccine developed by U.S. company Moderna, the final step in the EU's authorisation process.

"With the Moderna vaccine, the second one now authorised in the EU, we will have a further 160 million doses. And more vaccines will come," Ursula von der Leyen, the president of the European Commission, said in a statement.

European Union countries started vaccinations on Dec. 27 and are trying to catch up with countries including the U.S. or Israel where large numbers of people have already received the inoculation.

(Reporting by Marine Strauss @StraussMarine, editing by Kate Abnett)